2. Summary of included studies.

Characteristic	n	Percentage
Underlying condition
Cancer HIV/AIDS ICU Mixed at‐risk Organ transplant	23 1 16 7 2	46.9% 2.0% 32.7% 14.3% 4.1%
Age of patients
Adult Neonate Pediatric Mixed Unknown	26 3 3 5 12	53.1% 6.1% 6.1% 10.2% 24.5%
Study design
Prospective consecutive Retrospective consecutive Retrospective case‐control	26 12 11	53.1% 24.5% 22.4%
Fungal type
Aspergillus only Candida only PJP only Mixed fungal types	12 10 3 24	24.5% 20.4% 6.1% 49.0%
Test brand
Fungitell Glucatell Fungitec‐G Wako Dynamiker Fungus	36 5 3 3 2	73.5% 10.2% 6.1% 6.1% 4.1%
Sampling strategy
Single sample Multiple samples Unknown	20 26 3	40.8% 53.1% 6.1%
Reference standard used
EORTC Proven Candida PJP microscopy/PCR Study‐specific	36 8 3 2	73.5% 16.3% 6.1% 4.1%
Low risk of bias
Participant selection Index test Reference standard Flow and timing	35 49 41 41	71.4% 100.0% 83.7% 83.7%

EORTC: European Organization for Research and Treatment of Cancer; ICU: intensive care unit; PCR: polymerase chain reaction; PJP: Pneumocystis jirovecii pneumonia.